Dr. Sulaiman Al-Habib Medical Services Group Bundle
Who Owns Dr. Sulaiman Al-Habib Medical Services Group Company?
The ownership structure of a company is a critical indicator of its strategic direction and accountability. A pivotal event in the history of Dr. Sulaiman Al-Habib Medical Services Group Company (HMG) was its highly successful Initial Public Offering (IPO) in March 2020, transforming it into a publicly traded entity.
Founded in 1995 by Dr. Sulaiman Al-Habib, HMG has grown into a leading private healthcare provider in the Middle East. As of December 2023, the group operated 25 medical facilities with over 1,900 beds, serving millions of patients annually across Saudi Arabia, the UAE, and Bahrain. This growth trajectory is further detailed in the Dr. Sulaiman Al-Habib Medical Services Group PESTEL Analysis.
Understanding the ownership evolution, from its founder's initial stakes to the dynamics of institutional and public shareholders post-IPO, is essential for appreciating HMG's governance and impact.
Who Founded Dr. Sulaiman Al-Habib Medical Services Group?
Dr Sulaiman Al Habib Medical Services Group ownership traces back to its founder, Dr. Sulaiman Abdulaziz Al-Habib. This pediatrician established the group in 1995 with a clear vision for patient-centric healthcare. His early leadership laid the groundwork for the organization's expansion and eventual public offering.
| Founder | Primary Role | Establishment Year |
| Dr. Sulaiman Abdulaziz Al-Habib | Founder and Visionary | 1995 |
Dr. Sulaiman Al-Habib envisioned a medical group focused on patient care, innovation, and accessibility. This foundational principle guided the initial establishment of healthcare facilities and related services.
The company's initial operations centered on developing and managing healthcare facilities, pharmacies, and various supporting services. This laid the operational foundation for future growth.
Prior to the company's public listing in 2020, Dr. Sulaiman Al-Habib held a significant majority stake. At the time of the IPO, his ownership stood at 49%, underscoring his substantial control.
There is no public information detailing early angel investors or significant stakes acquired by friends and family during the company's private inception. The ownership structure was primarily driven by the founder.
Dr. Sulaiman Al-Habib's substantial ownership stake at the time of the IPO reflects his continued influence over the group's strategic direction. He remains a pivotal figure in the company's governance.
Before founding the group, Dr. Sulaiman Al-Habib served as the head of pediatrics at the Security Forces Hospital in Riyadh from 1988 to 1991. This experience provided valuable insights into healthcare management.
The ownership structure of Dr Sulaiman Al Habib Medical Services Group is largely defined by its founder, Dr. Sulaiman Abdulaziz Al-Habib. His significant stake, amounting to 49% at the time of the company's public listing in 2020, highlights his central role in the organization's history and ongoing operations. This ownership reflects his foundational contributions and continued strategic influence over the Al Habib Medical Group. For a deeper understanding of the company's journey, refer to the Brief History of Dr. Sulaiman Al-Habib Medical Services Group.
Dr. Sulaiman Al-Habib is the primary owner and founder of the medical services group. His substantial stake at the 2020 IPO indicates his continued control and significant influence over the company's direction.
- Founder: Dr. Sulaiman Abdulaziz Al-Habib
- Establishment Year: 1995
- Ownership at IPO (2020): 49%
- Early focus: Healthcare facilities, pharmacies, ancillary services
- No public record of early angel investors or significant family/friend stakes
Dr. Sulaiman Al-Habib Medical Services Group SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Dr. Sulaiman Al-Habib Medical Services Group’s Ownership Changed Over Time?
The ownership structure of Dr. Sulaiman Al-Habib Medical Services Group (HMG) saw a significant shift with its Initial Public Offering (IPO) on the Saudi Stock Exchange in March 2020. This event offered 15% of the company's shares, raising substantial capital and altering the distribution of ownership among various stakeholders.
| Shareholder | Ownership Stake (as of July 2025/Feb 2024) | Notes |
|---|---|---|
| Dr. Sulaiman Al-Habib | 40% | Founder and Chairman |
| Mohammed Abdulaziz Al Habib and Sons Holding Company | Approximately 28.8% (as of Feb 2024) | Transferred 17.43 million shares to an affiliated portfolio in Feb 2024 |
| SNB Capital Co. | Major Institutional Investor | |
| State Street Global Advisors Ltd. | Major Institutional Investor | |
| Ashmore Investment Management Ltd. | Major Institutional Investor | |
| Mercer Global Investments Europe Ltd. | Major Institutional Investor |
Following its IPO, Dr. Sulaiman Al-Habib Medical Services Group has maintained a clear ownership hierarchy, with its founder, Dr. Sulaiman Al-Habib, retaining a substantial stake. The evolution of shareholding also highlights the active participation of institutional investors and strategic adjustments made by major holding companies, reflecting the dynamic nature of public market investments. Understanding these key stakeholders is crucial for grasping the Revenue Streams & Business Model of Dr. Sulaiman Al-Habib Medical Services Group.
Dr. Sulaiman Al-Habib Medical Services Group's ownership is characterized by a significant founder's stake and a growing presence of institutional investors. These entities play a vital role in the company's strategic direction and market valuation.
- Dr. Sulaiman Al-Habib, the founder, holds 40% of the company's shares as of July 2025.
- Mohammed Abdulaziz Al Habib and Sons Holding Company's stake adjusted to 28.8% after a share transfer in February 2024.
- The IPO in March 2020 offered 15% of the total share capital.
- Major institutional investors include SNB Capital Co., State Street Global Advisors Ltd., Ashmore Investment Management Ltd., and Mercer Global Investments Europe Ltd.
- As of July 21, 2025, HMG's market capitalization reached $23.7 billion.
Dr. Sulaiman Al-Habib Medical Services Group PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Dr. Sulaiman Al-Habib Medical Services Group’s Board?
The Board of Directors for Dr. Sulaiman Al-Habib Medical Services Group, as of December 2024, is comprised of key individuals who guide the company's strategic direction. Dr. Sulaiman Al-Habib chairs the board, with Obaid Al Rasheed serving as Vice Chairman. Other members include Rasheed Al Rasheed, Abdulrahman Al Turaigi, Ibrahim Al-Jamez, Saleh Al Habib, Professor Abdullah Al-Herbsh, Faisal Al Nassar, and Hesham Al Habib.
| Board Member | Role | Additional Affiliation |
| Dr. Sulaiman Al-Habib | Chairman | Chairman of Dr. Sulaiman Al-Habib Investment Company |
| Obaid Al Rasheed | Vice Chairman | |
| Rasheed Al Rasheed | Board Member | |
| Abdulrahman Al Turaigi | Board Member | |
| Ibrahim Al-Jamez | Board Member | |
| Saleh Al Habib | Board Member | |
| Professor Abdullah Al-Herbsh | Board Member | |
| Faisal Al Nassar | Board Member, Group CEO and CFO | |
| Hesham Al Habib | Board Member |
The voting power within Dr. Sulaiman Al-Habib Medical Services Group is largely concentrated, reflecting a significant founder's stake. The company generally operates under a one-share-one-vote principle, standard for Saudi joint-stock entities. For shareholder meetings to be valid, at least half of the company's voting shares must be represented; a second meeting can proceed regardless of attendance numbers if the initial quorum is not met. Dr. Sulaiman Al-Habib holds a substantial 40% stake, which, when combined with other family interests, provides him and his family with considerable control over the company's decisions. There have been no public reports of proxy fights or activist campaigns impacting the governance of the Al Habib Medical Group.
The concentration of voting power significantly influences corporate governance and strategic direction. Understanding who owns Al Habib Medical Group is key to grasping its operational framework.
- Dr. Sulaiman Al-Habib's 40% stake is a primary driver of voting power.
- Family representation on the board ensures continued influence.
- The one-share-one-vote principle is standard for Saudi joint-stock companies.
- Shareholder meeting quorum requirements ensure broad participation for major decisions.
- Faisal Al Nassar's dual role as CEO, CFO, and board member highlights integrated leadership.
Dr. Sulaiman Al-Habib Medical Services Group Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Dr. Sulaiman Al-Habib Medical Services Group’s Ownership Landscape?
Over the past few years, the ownership landscape of Dr Sulaiman Al Habib Medical Services Group has seen internal adjustments, primarily involving major shareholders. These shifts reflect strategic management of holdings rather than a change in ultimate control, maintaining a consistent family-centric ownership structure.
| Shareholder | Previous Stake (approx.) | Recent Transaction (Feb 2024) | Current Stake (approx.) |
|---|---|---|---|
| Mohammed Abdulaziz Al Habib and Sons Holding Company | 33.753% | Transferred 17.43 million shares to an affiliated investment portfolio | Adjusted direct ownership percentage |
The company's strategic direction is heavily influenced by its aggressive expansion plans, aiming to significantly increase its operational capacity. This growth is supported by substantial capital investments, underscoring a commitment to expanding its footprint in the healthcare sector. The financial performance in 2024 demonstrates strong revenue growth and increased profitability, aligning with the outcomes of these expansionary efforts.
New facilities in Riyadh and Jeddah became operational in 2024. Further expansion in Jeddah and Al-Kharj is slated for mid-2025.
The company anticipates an 89% increase in bed capacity by 2028, growing from 1,913 beds in 2023 to 3,609 beds.
Sales reached SAR 11,200.43 million, a 17.79% increase year-over-year. Net income grew by 13.16% to SAR 2,315.29 million.
The financial contributions from new hospitals, such as the one in Al-Kharj, are expected to be reflected starting from the second quarter of 2025.
Dr. Sulaiman Al-Habib Medical Services Group Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Dr. Sulaiman Al-Habib Medical Services Group Company?
- What is Competitive Landscape of Dr. Sulaiman Al-Habib Medical Services Group Company?
- What is Growth Strategy and Future Prospects of Dr. Sulaiman Al-Habib Medical Services Group Company?
- How Does Dr. Sulaiman Al-Habib Medical Services Group Company Work?
- What is Sales and Marketing Strategy of Dr. Sulaiman Al-Habib Medical Services Group Company?
- What are Mission Vision & Core Values of Dr. Sulaiman Al-Habib Medical Services Group Company?
- What is Customer Demographics and Target Market of Dr. Sulaiman Al-Habib Medical Services Group Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.